Tivic Health Announces Launch of New and Improved ClearUP 2.0
2024年1月8日 - 11:00PM
ビジネスワイヤ(英語)
Tivic Health® Systems, Inc. (“Tivic”) (Nasdaq: TIVC), a
commercial-phase health technology company that develops and
commercializes bioelectronic medicine, announced today the launch
of the second generation of Tivic ClearUP. The new and improved
Tivic ClearUP 2.0, now with a new chip for power management for
faster charge and longer battery life, is available starting today
on TivicHealth.com.
ClearUP 2.0 is a clinically proven way to clear congestion and
relieve sinus pain. It is an FDA-approved, 100% drug-free and
non-addictive way to reduce sinus pain, pressure, sinus headaches,
and congestion due to colds, flu, and allergies.
Based on clinical trials of ClearUP:
- 88% of subjects see meaningful improvement in congestion
symptoms
- 74% experience pain relief on the first use
- 82% prefer ClearUP to other sinus treatments
- 10 minutes after treatment, patients reported relief of sinus
pain
ClearUP provides an effective, non-invasive and drug-free
alternative to over-the-counter medications, using gentle
microcurrents to treat symptoms of sinus and nasal inflammation.
The bioelectronic device locates treatment points along the cheek,
nose and brow and emits gentle microcurrent stimulation for
precise, targeted relief that you control. There is no mess, pills
or sprays, and its ergonomic design fits in the palm of your hand
so you can bring it everywhere you go and experience relief from
sinus pain anytime, anywhere. The use of neuromodulation devices is
growing throughout the medical industry, offering a new method of
helping patients who do not respond to existing remedies.
About Tivic
Tivic Health Systems, Inc. is a commercial-phase health
technology company delivering non-invasive bioelectronic treatments
that provide consumers with a choice in the treatment of
inflammation and certain other related conditions. For more
information visit https://tivichealth.com @TivicHealth.
Forward-Looking Statements
This press release may contain “forward-looking statements” that
are subject to substantial risks and uncertainties. All statements,
other than statements of historical fact, contained in this press
release are forward-looking statements. Forward-looking statements
contained in this press release may be identified by the use of
words such as “anticipate,” “believe,” “contemplate,” “could,”
“estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,”
“potential,” “predict,” “project,” “target,” “aim,” “should,”
“will” “would,” or the negative of these words or other similar
expressions, although not all forward-looking statements contain
these words. Forward-looking statements are based on Tivic Health
Systems, Inc.’s current expectations and are subject to inherent
uncertainties, risks, and assumptions that are difficult to
predict. Further, certain forward-looking statements are based on
assumptions as to future events that may not prove to be accurate.
Actual results could differ materially from those contained in any
forward-looking statement as a result of various factors,
including, without limitation: unknown or unexpected defects with
the new ClearUP 2.0 design; market and other conditions; supply
chain constraints; macroeconomic factors; and unexpected costs,
charges or expenses that reduce Tivic’s capital resources. Given
these risks and uncertainties, you are cautioned not to place undue
reliance on such forward-looking statements. For a discussion of
other risks and uncertainties, and other important factors, any of
which could cause Tivic’s actual results to differ from those
contained in the forward-looking statements, see Tivic’s filings
with the SEC, including, its Annual Report on Form 10-K for the
year ended December 31, 2022, filed with the SEC on March 31, 2023,
under the heading “Risk Factors,” as well as the company’s
subsequent filings with the SEC. Forward-looking statements
contained in this press release are made as of this date, and Tivic
Health Systems, Inc. undertakes no duty to update such information
except as required by applicable law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240108148912/en/
Max Borges Agency Tivic@maxborgesagency.com
Tivic Health Systems (NASDAQ:TIVC)
過去 株価チャート
から 5 2024 まで 6 2024
Tivic Health Systems (NASDAQ:TIVC)
過去 株価チャート
から 6 2023 まで 6 2024